NCT00174824View on ClinicalTrials.gov

Comparison of Insulin Glargine and NPH Human Insulin in Progression of Diabetic Retinopathy in Type 2 Diabetic Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

1,024

Participants

Timeline

Start Date

June 30, 2001

Primary Completion Date

April 30, 2007

Study Completion Date

April 30, 2007

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Insulin glargine

Trial Locations (2)

08807

Sanofi-Aventis Administrative Office, Bridgewater

Unknown

Sanofi-Aventis Administrative Office, Laval

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY